trending Market Intelligence /marketintelligence/en/news-insights/trending/7gu-dxa_uuv2fqoinptpaq2 content esgSubNav
In This List

Ritter Pharmaceuticals implements 1-for-10 reverse stock split

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Ritter Pharmaceuticals implements 1-for-10 reverse stock split

Los Angeles-based Ritter Pharmaceuticals Inc. implemented a 1-for-10 reverse split of its common stock, effective March 23.

The split will reduce Ritter's issued and outstanding common shares to 4,940,652 from 49,406,521.

Corporate Stock Transfer Inc. is acting as exchange agent for the split.